HEADER MEMBRANE PROTEIN 31-MAY-23 8JJO TITLE CRYO-EM STRUCTURE OF THE BETA2AR-MBRIL/1B3 FAB/GLUE COMPLEX WITH AN TITLE 2 ANTAGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-2 ADRENERGIC RECEPTOR,BETA-2 ADRENERGIC RECEPTOR, COMPND 3 SOLUBLE CYTOCHROME B562; COMPND 4 CHAIN: F; COMPND 5 SYNONYM: BETA-2 ADRENORECEPTOR,BETA-2 ADRENOCEPTOR; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: ADRB2, ADRB2R, B2AR, CYBC; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS COMPLEX, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR B.B.HE,Y.X.ZHONG,Q.GUO,Y.Y.TAO REVDAT 2 03-JAN-24 8JJO 1 JRNL REVDAT 1 06-SEP-23 8JJO 0 JRNL AUTH Q.GUO,B.HE,Y.ZHONG,H.JIAO,Y.REN,Q.WANG,Q.GE,Y.GAO,X.LIU, JRNL AUTH 2 Y.DU,H.HU,Y.TAO JRNL TITL A METHOD FOR STRUCTURE DETERMINATION OF GPCRS IN VARIOUS JRNL TITL 2 STATES. JRNL REF NAT.CHEM.BIOL. V. 20 74 2024 JRNL REFN ESSN 1552-4469 JRNL PMID 37580554 JRNL DOI 10.1038/S41589-023-01389-0 REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.400 REMARK 3 NUMBER OF PARTICLES : 173740 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8JJO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 06-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1300037977. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : CELL REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CHIMERIC BETA-2 ADRENERGIC REMARK 245 RECEPTOR REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 5000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5200.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET F 5 REMARK 465 LYS F 6 REMARK 465 THR F 7 REMARK 465 ILE F 8 REMARK 465 ILE F 9 REMARK 465 ALA F 10 REMARK 465 LEU F 11 REMARK 465 SER F 12 REMARK 465 TYR F 13 REMARK 465 ILE F 14 REMARK 465 PHE F 15 REMARK 465 CYS F 16 REMARK 465 LEU F 17 REMARK 465 VAL F 18 REMARK 465 PHE F 19 REMARK 465 ALA F 20 REMARK 465 ASP F 21 REMARK 465 TYR F 22 REMARK 465 LYS F 23 REMARK 465 ASP F 24 REMARK 465 ASP F 25 REMARK 465 ASP F 26 REMARK 465 ASP F 27 REMARK 465 LYS F 28 REMARK 465 SER F 274 REMARK 465 GLY F 275 REMARK 465 SER F 276 REMARK 465 GLY F 277 REMARK 465 LYS F 408 REMARK 465 ILE F 409 REMARK 465 ALA F 410 REMARK 465 ALA F 411 REMARK 465 LEU F 412 REMARK 465 LYS F 413 REMARK 465 GLU F 414 REMARK 465 LYS F 415 REMARK 465 ILE F 416 REMARK 465 ALA F 417 REMARK 465 ALA F 418 REMARK 465 LEU F 419 REMARK 465 LYS F 420 REMARK 465 GLU F 421 REMARK 465 LYS F 422 REMARK 465 ILE F 423 REMARK 465 ALA F 424 REMARK 465 ALA F 425 REMARK 465 LEU F 426 REMARK 465 LYS F 427 REMARK 465 GLU F 428 REMARK 465 ALA F 429 REMARK 465 GLU F 430 REMARK 465 GLU F 431 REMARK 465 LYS F 432 REMARK 465 ARG F 433 REMARK 465 ALA F 434 REMARK 465 SER F 435 REMARK 465 ARG F 436 REMARK 465 LEU F 437 REMARK 465 GLU F 438 REMARK 465 GLU F 439 REMARK 465 GLU F 440 REMARK 465 LEU F 441 REMARK 465 ARG F 442 REMARK 465 ARG F 443 REMARK 465 ARG F 444 REMARK 465 LEU F 445 REMARK 465 THR F 446 REMARK 465 GLU F 447 REMARK 465 GLY F 448 REMARK 465 SER F 449 REMARK 465 HIS F 450 REMARK 465 HIS F 451 REMARK 465 HIS F 452 REMARK 465 HIS F 453 REMARK 465 HIS F 454 REMARK 465 HIS F 455 REMARK 465 HIS F 456 REMARK 465 HIS F 457 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR F 219 O LEU F 339 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL F 86 -55.40 -125.52 REMARK 500 PRO F 138 -176.22 -69.36 REMARK 500 PHE F 139 -5.04 68.78 REMARK 500 GLN F 170 2.74 -68.80 REMARK 500 THR F 177 52.15 -93.50 REMARK 500 CYS F 190 152.04 67.13 REMARK 500 CYS F 191 22.22 -142.14 REMARK 500 THR F 239 0.46 -68.58 REMARK 500 LYS F 249 49.65 -94.66 REMARK 500 ASP F 251 -179.99 177.99 REMARK 500 ASN F 252 71.01 58.34 REMARK 500 LYS F 300 -178.21 61.54 REMARK 500 ASN F 303 -165.64 -79.37 REMARK 500 LYS F 306 -102.04 55.50 REMARK 500 ASN F 368 -0.12 63.00 REMARK 500 LYS F 372 47.81 -85.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-36361 RELATED DB: EMDB REMARK 900 CRYOEM STRUCTURE OF THE BETA2AR-MBRIL/1B3 FAB/GLUE COMPLEX WITH REMARK 900 ANTAGONIST DBREF 8JJO F 29 230 UNP P07550 ADRB2_HUMAN 29 230 DBREF 8JJO F 231 329 PDB 8JJO 8JJO 231 329 DBREF 8JJO F 330 407 UNP P07550 ADRB2_HUMAN 263 340 SEQADV 8JJO MET F 5 UNP P07550 INITIATING METHIONINE SEQADV 8JJO LYS F 6 UNP P07550 EXPRESSION TAG SEQADV 8JJO THR F 7 UNP P07550 EXPRESSION TAG SEQADV 8JJO ILE F 8 UNP P07550 EXPRESSION TAG SEQADV 8JJO ILE F 9 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 10 UNP P07550 EXPRESSION TAG SEQADV 8JJO LEU F 11 UNP P07550 EXPRESSION TAG SEQADV 8JJO SER F 12 UNP P07550 EXPRESSION TAG SEQADV 8JJO TYR F 13 UNP P07550 EXPRESSION TAG SEQADV 8JJO ILE F 14 UNP P07550 EXPRESSION TAG SEQADV 8JJO PHE F 15 UNP P07550 EXPRESSION TAG SEQADV 8JJO CYS F 16 UNP P07550 EXPRESSION TAG SEQADV 8JJO LEU F 17 UNP P07550 EXPRESSION TAG SEQADV 8JJO VAL F 18 UNP P07550 EXPRESSION TAG SEQADV 8JJO PHE F 19 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 20 UNP P07550 EXPRESSION TAG SEQADV 8JJO ASP F 21 UNP P07550 EXPRESSION TAG SEQADV 8JJO TYR F 22 UNP P07550 EXPRESSION TAG SEQADV 8JJO LYS F 23 UNP P07550 EXPRESSION TAG SEQADV 8JJO ASP F 24 UNP P07550 EXPRESSION TAG SEQADV 8JJO ASP F 25 UNP P07550 EXPRESSION TAG SEQADV 8JJO ASP F 26 UNP P07550 EXPRESSION TAG SEQADV 8JJO ASP F 27 UNP P07550 EXPRESSION TAG SEQADV 8JJO LYS F 28 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 187 UNP P07550 ASN 187 CONFLICT SEQADV 8JJO SER F 394 UNP P07550 CYS 327 CONFLICT SEQADV 8JJO LYS F 408 UNP P07550 EXPRESSION TAG SEQADV 8JJO ILE F 409 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 410 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 411 UNP P07550 EXPRESSION TAG SEQADV 8JJO LEU F 412 UNP P07550 EXPRESSION TAG SEQADV 8JJO LYS F 413 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 414 UNP P07550 EXPRESSION TAG SEQADV 8JJO LYS F 415 UNP P07550 EXPRESSION TAG SEQADV 8JJO ILE F 416 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 417 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 418 UNP P07550 EXPRESSION TAG SEQADV 8JJO LEU F 419 UNP P07550 EXPRESSION TAG SEQADV 8JJO LYS F 420 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 421 UNP P07550 EXPRESSION TAG SEQADV 8JJO LYS F 422 UNP P07550 EXPRESSION TAG SEQADV 8JJO ILE F 423 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 424 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 425 UNP P07550 EXPRESSION TAG SEQADV 8JJO LEU F 426 UNP P07550 EXPRESSION TAG SEQADV 8JJO LYS F 427 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 428 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 429 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 430 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 431 UNP P07550 EXPRESSION TAG SEQADV 8JJO LYS F 432 UNP P07550 EXPRESSION TAG SEQADV 8JJO ARG F 433 UNP P07550 EXPRESSION TAG SEQADV 8JJO ALA F 434 UNP P07550 EXPRESSION TAG SEQADV 8JJO SER F 435 UNP P07550 EXPRESSION TAG SEQADV 8JJO ARG F 436 UNP P07550 EXPRESSION TAG SEQADV 8JJO LEU F 437 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 438 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 439 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 440 UNP P07550 EXPRESSION TAG SEQADV 8JJO LEU F 441 UNP P07550 EXPRESSION TAG SEQADV 8JJO ARG F 442 UNP P07550 EXPRESSION TAG SEQADV 8JJO ARG F 443 UNP P07550 EXPRESSION TAG SEQADV 8JJO ARG F 444 UNP P07550 EXPRESSION TAG SEQADV 8JJO LEU F 445 UNP P07550 EXPRESSION TAG SEQADV 8JJO THR F 446 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLU F 447 UNP P07550 EXPRESSION TAG SEQADV 8JJO GLY F 448 UNP P07550 EXPRESSION TAG SEQADV 8JJO SER F 449 UNP P07550 EXPRESSION TAG SEQADV 8JJO HIS F 450 UNP P07550 EXPRESSION TAG SEQADV 8JJO HIS F 451 UNP P07550 EXPRESSION TAG SEQADV 8JJO HIS F 452 UNP P07550 EXPRESSION TAG SEQADV 8JJO HIS F 453 UNP P07550 EXPRESSION TAG SEQADV 8JJO HIS F 454 UNP P07550 EXPRESSION TAG SEQADV 8JJO HIS F 455 UNP P07550 EXPRESSION TAG SEQADV 8JJO HIS F 456 UNP P07550 EXPRESSION TAG SEQADV 8JJO HIS F 457 UNP P07550 EXPRESSION TAG SEQRES 1 F 453 MET LYS THR ILE ILE ALA LEU SER TYR ILE PHE CYS LEU SEQRES 2 F 453 VAL PHE ALA ASP TYR LYS ASP ASP ASP ASP LYS ASP GLU SEQRES 3 F 453 VAL TRP VAL VAL GLY MET GLY ILE VAL MET SER LEU ILE SEQRES 4 F 453 VAL LEU ALA ILE VAL PHE GLY ASN VAL LEU VAL ILE THR SEQRES 5 F 453 ALA ILE ALA LYS PHE GLU ARG LEU GLN THR VAL THR ASN SEQRES 6 F 453 TYR PHE ILE THR SER LEU ALA CYS ALA ASP LEU VAL MET SEQRES 7 F 453 GLY LEU ALA VAL VAL PRO PHE GLY ALA ALA HIS ILE LEU SEQRES 8 F 453 MET LYS MET TRP THR PHE GLY ASN PHE TRP CYS GLU PHE SEQRES 9 F 453 TRP THR SER ILE ASP VAL LEU CYS VAL THR ALA SER ILE SEQRES 10 F 453 GLU THR LEU CYS VAL ILE ALA VAL ASP ARG TYR PHE ALA SEQRES 11 F 453 ILE THR SER PRO PHE LYS TYR GLN SER LEU LEU THR LYS SEQRES 12 F 453 ASN LYS ALA ARG VAL ILE ILE LEU MET VAL TRP ILE VAL SEQRES 13 F 453 SER GLY LEU THR SER PHE LEU PRO ILE GLN MET HIS TRP SEQRES 14 F 453 TYR ARG ALA THR HIS GLN GLU ALA ILE ASN CYS TYR ALA SEQRES 15 F 453 GLU GLU THR CYS CYS ASP PHE PHE THR ASN GLN ALA TYR SEQRES 16 F 453 ALA ILE ALA SER SER ILE VAL SER PHE TYR VAL PRO LEU SEQRES 17 F 453 VAL ILE MET VAL PHE VAL TYR SER ARG VAL PHE GLN GLU SEQRES 18 F 453 ALA LYS ARG GLN LEU ALA ASP LEU GLU ASP ASN TRP GLU SEQRES 19 F 453 THR LEU ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP SEQRES 20 F 453 ASN ALA ALA GLN VAL LYS ASP ALA LEU THR LYS MET ARG SEQRES 21 F 453 ALA ALA ALA LEU ASP ALA GLN LYS ALA SER GLY SER GLY SEQRES 22 F 453 SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE ASP ILE SEQRES 23 F 453 LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU ALA ASN SEQRES 24 F 453 GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA GLU GLN SEQRES 25 F 453 LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS TYR LEU SEQRES 26 F 453 LYS PHE CYS LEU LYS GLU HIS LYS ALA LEU LYS THR LEU SEQRES 27 F 453 GLY ILE ILE MET GLY THR PHE THR LEU CYS TRP LEU PRO SEQRES 28 F 453 PHE PHE ILE VAL ASN ILE VAL HIS VAL ILE GLN ASP ASN SEQRES 29 F 453 LEU ILE ARG LYS GLU VAL TYR ILE LEU LEU ASN TRP ILE SEQRES 30 F 453 GLY TYR VAL ASN SER GLY PHE ASN PRO LEU ILE TYR SER SEQRES 31 F 453 ARG SER PRO ASP PHE ARG ILE ALA PHE GLN GLU LEU LEU SEQRES 32 F 453 LYS ILE ALA ALA LEU LYS GLU LYS ILE ALA ALA LEU LYS SEQRES 33 F 453 GLU LYS ILE ALA ALA LEU LYS GLU ALA GLU GLU LYS ARG SEQRES 34 F 453 ALA SER ARG LEU GLU GLU GLU LEU ARG ARG ARG LEU THR SEQRES 35 F 453 GLU GLY SER HIS HIS HIS HIS HIS HIS HIS HIS HET JTZ F 501 18 HETNAM JTZ (2S)-1-[(1-METHYLETHYL)AMINO]-3-(2-PROP-2-EN-1- HETNAM 2 JTZ YLPHENOXY)PROPAN-2-OL FORMUL 2 JTZ C15 H23 N O2 HELIX 1 AA1 ASP F 29 PHE F 61 1 33 HELIX 2 AA2 THR F 66 VAL F 86 1 21 HELIX 3 AA3 VAL F 86 MET F 96 1 11 HELIX 4 AA4 CYS F 106 ALA F 134 1 29 HELIX 5 AA5 THR F 146 GLN F 170 1 25 HELIX 6 AA6 GLU F 180 ALA F 186 5 7 HELIX 7 AA7 ASN F 196 SER F 207 1 12 HELIX 8 AA8 VAL F 210 TRP F 237 1 28 HELIX 9 AA9 LEU F 240 ILE F 247 1 8 HELIX 10 AB1 ASN F 252 ALA F 273 1 22 HELIX 11 AB2 PRO F 279 LYS F 300 1 22 HELIX 12 AB3 GLU F 309 GLN F 366 1 58 HELIX 13 AB4 GLU F 373 SER F 386 1 14 HELIX 14 AB5 GLY F 387 SER F 394 1 8 HELIX 15 AB6 SER F 396 GLU F 405 1 10 SSBOND 1 CYS F 106 CYS F 191 1555 1555 2.03 SSBOND 2 CYS F 184 CYS F 190 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000